Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 19

1.

Hydrogel biophysical properties instruct coculture-mediated osteogenic potential.

Murphy KC, Stilhano RS, Mitra D, Zhou D, Batarni S, Silva EA, Leach JK.

FASEB J. 2016 Jan;30(1):477-86. doi: 10.1096/fj.15-279984. Epub 2015 Oct 6.

PMID:
26443826
2.

Expression of bone morphogenetic protein 2 in rabbit radial defect site with different lengths.

Hou GZ, Xu F, Li WJ, Zhu XM, Song XH, Zhan YL.

Int J Clin Exp Med. 2015 Jun 15;8(6):9229-38. eCollection 2015.

3.

Effects of transforming growth factor β-1 infected human bone marrow mesenchymal stem cells on high- and low-metastatic potential hepatocellular carcinoma.

Li T, Zhao S, Song B, Wei Z, Lu G, Zhou J, Huo T.

Eur J Med Res. 2015 May 24;20:56. doi: 10.1186/s40001-015-0144-2.

4.

Mesenchymal stem cell-based HSP70 promoter-driven VEGFA induction by resveratrol promotes angiogenesis in a mouse model.

Chen YB, Lan YW, Hung TH, Chen LG, Choo KB, Cheng WT, Lee HS, Chong KY.

Cell Stress Chaperones. 2015 Jul;20(4):643-52. doi: 10.1007/s12192-015-0588-x. Epub 2015 Apr 10.

5.

PDGF-AA promotes osteogenic differentiation and migration of mesenchymal stem cell by down-regulating PDGFRα and derepressing BMP-Smad1/5/8 signaling.

Li A, Xia X, Yeh J, Kua H, Liu H, Mishina Y, Hao A, Li B.

PLoS One. 2014 Dec 3;9(12):e113785. doi: 10.1371/journal.pone.0113785. eCollection 2014.

6.

Stem cells rejuvenate radiation-impaired vasculogenesis in murine distraction osteogenesis.

Deshpande SS, Gallagher KK, Donneys A, Nelson NS, Guys NP, Felice PA, Page EE, Sun H, Krebsbach PH, Buchman SR.

Plast Reconstr Surg. 2015 Mar;135(3):799-806. doi: 10.1097/PRS.0000000000001024.

PMID:
25415276
7.

Mesenchymal stromal cells express GARP/LRRC32 on their surface: effects on their biology and immunomodulatory capacity.

Carrillo-Galvez AB, Cobo M, Cuevas-Ocaña S, Gutiérrez-Guerrero A, Sánchez-Gilabert A, Bongarzone P, García-Pérez A, Muñoz P, Benabdellah K, Toscano MG, Martín F, Anderson P.

Stem Cells. 2015 Jan;33(1):183-95. doi: 10.1002/stem.1821.

8.

Enhanced trophic factor secretion by mesenchymal stem/stromal cells with Glycine-Histidine-Lysine (GHK)-modified alginate hydrogels.

Jose S, Hughbanks ML, Binder BY, Ingavle GC, Leach JK.

Acta Biomater. 2014 May;10(5):1955-64. doi: 10.1016/j.actbio.2014.01.020. Epub 2014 Jan 24.

9.

Lysophosphatidic acid enhances stromal cell-directed angiogenesis.

Binder BY, Sondergaard CS, Nolta JA, Leach JK.

PLoS One. 2013 Dec 2;8(12):e82134. doi: 10.1371/journal.pone.0082134. eCollection 2013.

10.

Lysophosphatidic acid protects human mesenchymal stromal cells from differentiation-dependent vulnerability to apoptosis.

Binder BY, Genetos DC, Leach JK.

Tissue Eng Part A. 2014 Apr;20(7-8):1156-64. doi: 10.1089/ten.TEA.2013.0487. Epub 2014 Feb 11.

11.

Susceptibility of human placenta derived mesenchymal stromal/stem cells to human herpesviruses infection.

Avanzi S, Leoni V, Rotola A, Alviano F, Solimando L, Lanzoni G, Bonsi L, Di Luca D, Marchionni C, Alvisi G, Ripalti A.

PLoS One. 2013 Aug 5;8(8):e71412. doi: 10.1371/journal.pone.0071412. Print 2013.

12.

Mesenchymal-to-endothelial transition in Kaposi sarcoma: a histogenetic hypothesis based on a case series and literature review.

Gurzu S, Ciortea D, Munteanu T, Kezdi-Zaharia I, Jung I.

PLoS One. 2013 Aug 6;8(8):e71530. doi: 10.1371/journal.pone.0071530. Print 2013.

13.

Vitexicarpin acts as a novel angiogenesis inhibitor and its target network.

Zhang B, Liu L, Zhao S, Wang X, Liu L, Li S.

Evid Based Complement Alternat Med. 2013;2013:278405. doi: 10.1155/2013/278405. Epub 2013 Feb 12.

14.

BMP2 is superior to BMP4 for promoting human muscle-derived stem cell-mediated bone regeneration in a critical-sized calvarial defect model.

Gao X, Usas A, Lu A, Tang Y, Wang B, Chen CW, Li H, Tebbets JC, Cummins JH, Huard J.

Cell Transplant. 2013;22(12):2393-408. doi: 10.3727/096368912X658854. Epub 2012 Nov 1.

15.

Surface tethered epidermal growth factor protects proliferating and differentiating multipotential stromal cells from FasL-induced apoptosis.

Rodrigues M, Blair H, Stockdale L, Griffith L, Wells A.

Stem Cells. 2013 Jan;31(1):104-16. doi: 10.1002/stem.1215.

16.

Differentiation-dependent secretion of proangiogenic factors by mesenchymal stem cells.

Hoch AI, Binder BY, Genetos DC, Leach JK.

PLoS One. 2012;7(4):e35579. doi: 10.1371/journal.pone.0035579. Epub 2012 Apr 20.

17.

The bone-forming effects of HIF-1α-transduced BMSCs promote osseointegration with dental implant in canine mandible.

Zou D, He J, Zhang K, Dai J, Zhang W, Wang S, Zhou J, Huang Y, Zhang Z, Jiang X.

PLoS One. 2012;7(3):e32355. doi: 10.1371/journal.pone.0032355. Epub 2012 Mar 5.

18.

Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease.

Ranganath SH, Levy O, Inamdar MS, Karp JM.

Cell Stem Cell. 2012 Mar 2;10(3):244-58. doi: 10.1016/j.stem.2012.02.005. Review.

19.

Concise review: Induced pluripotent stem cell-derived mesenchymal stem cells: progress toward safe clinical products.

Jung Y, Bauer G, Nolta JA.

Stem Cells. 2012 Jan;30(1):42-7. doi: 10.1002/stem.727. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk